Quadracel 29 Unit

QUADRACEL 29 Unit is an inactivated polio vaccine designed to protect against polio. This intramuscular suspension is manufactured by Sanofi Pasteur Limited in Canada. Learn more about its uses and effects.

QUADRACEL 29 Unit is primarily used for the prevention of polio, a viral infection that can cause paralysis and other serious complications. This vaccine is typically administered to children as part of their routine immunization schedule. The vaccine works by stimulating the immune system to produce antibodies against the polio virus, providing protection against future infections.

Common effects of QUADRACEL 29 Unit may include mild soreness, redness, or swelling at the injection site. Some individuals may also experience low-grade fever, fatigue, or headache. These effects are usually mild and temporary, resolving within a few days. Serious side effects are rare but should be reported to a healthcare provider.

QUADRACEL 29 Unit should be stored and handled according to the manufacturer's guidelines to maintain its effectiveness. It is important to inform your healthcare provider about any allergies or medical conditions before receiving this vaccine. Individuals with a history of severe allergic reactions to previous polio vaccines or any components of QUADRACEL 29 Unit should avoid this vaccine.

QUADRACEL 29 Unit may interact with certain medications or other vaccines. It is generally recommended to avoid receiving other live vaccines simultaneously. Alcohol and other immunosuppressive drugs may affect the vaccine's efficacy. Always consult a healthcare provider before combining QUADRACEL 29 Unit with other treatments.